Replies to post #216400 on Biotech Values

[DewDiligence]

RCKT—(f/k/a ITEK)—sells 6.33M* shares @$13.25—a 13% discount to yesterday’s close:

https://finance.yahoo.com/news/rocket-pharmaceuticals-prices-public-offering-132500746.html

*Assuming exercise of underwriter’s option.

[DewDiligence]

RCKT +77% on phase-1 data—despite a public offering being announced before today’s open:

https://finance.yahoo.com/news/rocket-pharmaceuticals-announces-positive-gene-210000007.html

https://finance.yahoo.com/news/rocket-pharmaceuticals-announces-proposed-public-125100736.html